Feng et al. [45] were the first to demonstrate that electroacupuncture could significantly reduce the levels of fasting blood glucose (FPG) and fasting insulin (FINS) and the IR index (Homeostatic Model Assessment for Insulin Resistance) while improving insulin sensitivity in rats with high-lipid-induced NAFLD by acupuncture at the “Zu san li” (ST36), “Feng long” (ST40), “San yin jiao” (SP6), and “Tai chong” (LR3) acupoints. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.